-
F101624-5gFmoc-Phe(2-Me)-OH
-
-
F476955-100mgFmoc-Phe(4-Bocâ‚‚-guanidino)-OH
-
F476955-1gFmoc-Phe(4-Bocâ‚‚-guanidino)-OH
-
F476955-250mgFmoc-Phe(4-Bocâ‚‚-guanidino)-OH
-
F132427-1gAn N-Fmoc protected phenylalanine derivative and potentially useful synthetic intermediate.
-
F132427-250mgAn N-Fmoc protected phenylalanine derivative and potentially useful synthetic intermediate.
-
F132427-5gAn N-Fmoc protected phenylalanine derivative and potentially useful synthetic intermediate.
-
F478729-100mgDescriptionBuilding block [1] for the introduction by Fmoc SPPS of the hydrolytically stable phosphotyrosine analog phosphonodifluoromethylphenylalanine (F2Pmp) [2]. The pKa of F2Pmp more closely resembles that of a phosphate group making it better
-
F478729-25mgDescriptionBuilding block [1] for the introduction by Fmoc SPPS of the hydrolytically stable phosphotyrosine analog phosphonodifluoromethylphenylalanine (F2Pmp) [2]. The pKa of F2Pmp more closely resembles that of a phosphate group making it better
-
F478729-50mgDescriptionBuilding block [1] for the introduction by Fmoc SPPS of the hydrolytically stable phosphotyrosine analog phosphonodifluoromethylphenylalanine (F2Pmp) [2]. The pKa of F2Pmp more closely resembles that of a phosphate group making it better
-
F481472-1gDescriptionIntroduction of 4-sulfo-phenylalanine is an effective strategy for increasing solubility of a peptide. This amino acid has also been employed in analogs of angiotensin 2 [1], phytosulfokine [2], and cyclolinopeptide A [3]. Its